Stock listing
NASDAQ:ALLR Allarity Therapeutics, Inc. Stock
Home listing (NASDAQ) of Allarity Therapeutics, Inc.
Follow Allarity Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ALLR
$0.978 USD +0.107 (+12.3%)
Close on Nov 2, 2026
- Day range
- $0.874 – $1.030 USDNov 2, 2026
- Volume
- 166,742 sharesNov 2, 2026
- Market cap
- $15.56M USDAt the close on Nov 2, 2026 · price × 15.91M shares outstanding
- 52-week range
- $0.769 – $1.840 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $124,636 USDMedian day 90,822 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ALLR · Home | $0.978 USD | +0.107 (+12.3%) | 166,742 | $0.874 | $1.030 | $0.874 | $0.870 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ALLR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.978 | +0.107 | +12.3% | $0.874 | $1.030 | $0.874 | 166,742 | |
| $0.870 | -0.020 | -2.2% | $0.890 | $0.905 | $0.850 | 176,267 | |
| $0.890 | -0.060 | -6.3% | $0.938 | $0.938 | $0.854 | 150,036 | |
| $0.950 | +0.030 | +3.3% | $0.930 | $0.959 | $0.910 | 69,802 | |
| $0.920 | +0.005 | +0.5% | $0.930 | $0.960 | $0.900 | 136,055 | |
| $0.915 | +0.050 | +5.7% | $0.873 | $0.958 | $0.870 | 174,219 | |
| $0.865 | +0.019 | +2.2% | $0.842 | $0.896 | $0.840 | 70,570 | |
| $0.847 | -0.033 | -3.8% | $0.880 | $0.880 | $0.832 | 90,822 | |
| $0.880 | +0.004 | +0.4% | $0.873 | $0.902 | $0.840 | 88,643 | |
| $0.876 | +0.003 | +0.3% | $0.890 | $0.908 | $0.870 | 108,498 | |
| $0.873 | -0.022 | -2.5% | $0.898 | $0.915 | $0.821 | 86,465 | |
| $0.895 | +0.062 | +7.5% | $0.871 | $0.920 | $0.821 | 232,063 | |
| $0.833 | -0.041 | -4.6% | $0.897 | $0.900 | $0.800 | 323,178 | |
| $0.873 | +0.003 | +0.4% | $0.882 | $0.890 | $0.860 | 64,077 | |
| $0.870 | +0.010 | +1.2% | $0.880 | $0.910 | $0.830 | 111,400 | |
| $0.860 | -0.130 | -13.1% | $0.970 | $0.990 | $0.832 | 415,200 | |
| $0.990 | +0.008 | +0.8% | $0.995 | $1.040 | $0.990 | 97,000 | |
| $0.982 | -0.002 | -0.2% | $0.995 | $1.000 | $0.950 | 63,500 | |
| $0.984 | -0.001 | -0.1% | $1.020 | $1.040 | $0.981 | 81,000 | |
| $0.985 | -0.015 | -1.5% | $0.983 | $1.000 | $0.980 | 45,300 | |
| $1.000 | -0.040 | -3.8% | $1.040 | $1.050 | $0.990 | 39,100 | |
| $1.040 | 0.000 | 0.0% | $1.055 | $1.080 | $1.030 | 28,900 | |
| $1.040 | -0.010 | -1.0% | $1.060 | $1.079 | $1.010 | 74,100 | |
| $1.050 | +0.085 | +8.8% | $0.989 | $1.078 | $0.968 | 119,100 | |
| $0.965 | -0.003 | -0.3% | $0.972 | $1.000 | $0.940 | 167,600 | |
| $0.968 | -0.062 | -6.0% | $1.030 | $1.083 | $0.901 | 270,900 | |
| $1.030 | -0.060 | -5.5% | $1.090 | $1.100 | $1.030 | 43,700 | |
| $1.090 | +0.050 | +4.8% | $1.060 | $1.090 | $1.030 | 75,000 | |
| $1.040 | -0.070 | -6.3% | $1.150 | $1.150 | $1.010 | 167,500 | |
| $1.110 | -0.060 | -5.1% | $1.170 | $1.230 | $1.100 | 182,900 | |
| $1.170 | -0.040 | -3.3% | $1.200 | $1.200 | $1.130 | 114,900 | |
| $1.210 | +0.050 | +4.3% | $1.150 | $1.220 | $1.110 | 185,600 | |
| $1.160 | +0.005 | +0.4% | $1.130 | $1.267 | $1.130 | 160,400 | |
| $1.155 | +0.045 | +4.1% | $1.130 | $1.200 | $1.110 | 53,500 | |
| $1.110 | -0.060 | -5.1% | $1.160 | $1.195 | $1.090 | 154,500 | |
| $1.170 | -0.050 | -4.1% | $1.200 | $1.230 | $1.170 | 112,600 | |
| $1.220 | -0.030 | -2.4% | $1.320 | $1.340 | $1.210 | 205,200 | |
| $1.250 | -0.012 | -1.0% | $1.290 | $1.350 | $1.220 | 79,300 | |
| $1.262 | +0.012 | +1.0% | $1.280 | $1.290 | $1.250 | 65,300 | |
| $1.250 | -0.170 | -12.0% | $1.360 | $1.374 | $1.250 | 236,600 | |
| $1.420 | -0.010 | -0.7% | $1.440 | $1.450 | $1.400 | 54,500 | |
| $1.430 | +0.020 | +1.4% | $1.430 | $1.480 | $1.390 | 43,800 | |
| $1.410 | -0.010 | -0.7% | $1.450 | $1.490 | $1.370 | 124,000 | |
| $1.420 | +0.010 | +0.7% | $1.410 | $1.430 | $1.370 | 54,000 | |
| $1.410 | 0.000 | 0.0% | $1.410 | $1.440 | $1.320 | 106,300 | |
| $1.410 | +0.030 | +2.2% | $1.380 | $1.460 | $1.350 | 139,600 | |
| $1.380 | +0.040 | +3.0% | $1.350 | $1.430 | $1.340 | 49,800 | |
| $1.340 | +0.010 | +0.8% | $1.360 | $1.410 | $1.340 | 44,600 | |
| $1.330 | -0.060 | -4.3% | $1.380 | $1.410 | $1.330 | 57,919 | |
| $1.390 | -0.030 | -2.1% | $1.420 | $1.420 | $1.370 | 32,852 | |
| $1.420 | -0.010 | -0.7% | $1.410 | $1.492 | $1.380 | 111,700 | |
| $1.430 | 0.000 | 0.0% | $1.410 | $1.490 | $1.390 | 78,600 | |
| $1.430 | +0.080 | +5.9% | $1.350 | $1.490 | $1.350 | 117,800 | |
| $1.350 | +0.010 | +0.7% | $1.360 | $1.360 | $1.252 | 52,400 | |
| $1.340 | -0.030 | -2.2% | $1.390 | $1.390 | $1.310 | 56,600 | |
| $1.370 | +0.010 | +0.7% | $1.410 | $1.410 | $1.350 | 48,100 | |
| $1.360 | -0.040 | -2.9% | $1.420 | $1.430 | $1.255 | 152,200 | |
| $1.400 | -0.030 | -2.1% | $1.460 | $1.460 | $1.360 | 65,800 | |
| $1.430 | +0.020 | +1.4% | $1.430 | $1.550 | $1.360 | 133,800 | |
| $1.410 | +0.020 | +1.4% | $1.410 | $1.420 | $1.350 | 75,700 | |
| $1.390 | -0.010 | -0.7% | $1.390 | $1.430 | $1.350 | 50,800 | |
| $1.400 | +0.070 | +5.3% | $1.330 | $1.400 | $1.330 | 84,500 | |
| $1.330 | +0.020 | +1.5% | $1.350 | $1.354 | $1.270 | 108,100 | |
| $1.310 | +0.040 | +3.1% | $1.300 | $1.350 | $1.290 | 117,400 | |
| $1.270 | +0.060 | +5.0% | $1.230 | $1.300 | $1.230 | 65,000 |
- Ticker
- NASDAQ:ALLR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue
Latest deck · May 8, 2026
Investor Presentation (May 2026)
Investor deck · 22 slides
Latest news
Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue
Oct 30, 2026
Closed $0.87 (-2.2%) on Oct 30, 2026
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
Sep 30, 2026
Closed $1.05 (+8.8%) on Sep 30, 2026
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
Sep 28, 2026
Closed $0.968 (-6.0%) on Sep 28, 2026
Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development
Sep 15, 2026
Closed $1.11 (-5.1%) on Sep 15, 2026
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
Sep 11, 2026
Closed $1.22 (-2.4%) on Sep 11, 2026
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
Aug 14, 2026
Closed $1.37 (+0.7%) on Aug 14, 2026
Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration
Jul 7, 2026
Closed $1.13 (-5.8%) on Jul 7, 2026
Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
Jun 30, 2026
Closed $1.29 (-0.8%) on Jun 30, 2026
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
Jun 18, 2026
Closed $1.43 (+6.7%) on Jun 18, 2026
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
May 15, 2026
Closed $1.43 (+5.9%) on May 18, 2026
Decks
Investor Presentation (May 2026)
Investor deck · 22 slides · May 8, 2026
Investor Presentation (May 2025)
Investor deck · 24 slides · May 2025
Corporate Update (February 2024)
Corporate update · 16 slides · February 2024
Investor Presentation (December 2023)
Investor deck · 45 slides · Dec 6, 2023
Allarity Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 106 in all · newest Oct 30, 2026 · oldest 2022
- Decks
- 13 decks · latest May 8, 2026
Where Allarity Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ALLR · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ALLR | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Allarity Therapeutics, Inc.